Headache News and Research

Latest Headache News and Research

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, according to a study published in the December 13, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Dec 2017

Opioids after surgery left her addicted. Is that a medical error?

In April this year, Katie Herzog checked into a Boston teaching hospital for what turned out to be a nine-hour-long back surgery.

11 Dec 2017

Using atraumatic needles for lumbar punctures decreases risk of complications

The type of needle used during a lumbar puncture makes a significant difference in the subsequent occurrence of headache, nerve irritation and hearing disturbance in patients, according to a study by Hamilton medical researchers.

7 Dec 2017

Intensive weight management program can help people with type 2 diabetes achieve remission

Type 2 diabetes can be reversed following an intensive weight management program, according a randomized trial in adults who have had the condition for up to 6 years, published in The Lancet.

6 Dec 2017

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

New drugs Erenumab and Fremanezumab show promise for migraine

Migraine headaches affect thousands of Americans and millions worldwide. There are several medications that are being prescribed for migraines and for many these do not work well.

30 Nov 2017

New immunotherapy study shows positive results in chronic migraine sufferers

A new study of fremanezumab, an immunotherapy that counteracts one of the molecules released during migraine, was found successful in reducing the number of days that chronic migraine sufferers experienced headaches.

30 Nov 2017

Tiny markers in saliva can be used to diagnose duration of a concussion in kids

Researchers at the Penn State College of Medicine have found that tiny molecules present in the saliva can predict the occurrence, length and duration of a concussion in a child. The study titled, “Association of Salivary MicroRNA Changes With Prolonged Concussion Symptoms”, was published in the latest issue of JAMA Pediatrics on the 20th of November 2017.

20 Nov 2017

Small molecules in saliva may offer clues to diagnose and predict duration of concussions

Diagnosing a concussion can sometimes be a guessing game, but clues taken from small molecules in saliva may be able to help diagnose and predict the duration of concussions in children, according to researchers at Penn State College of Medicine.

20 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

Can apps slay the medical bill dragon?

Rachael Norman needed to submit a pile of out-of-network medical bills to her insurance company for reimbursement. Short on time, she started searching for a company that could do that tedious work for her.

15 Nov 2017

FDA warns consumers about injuries, disfigurement from using illegal injectable silicone

The U.S. Food and Drug Administration today issued a safety communication to warn consumers and health care practitioners about the serious injuries and disfigurement that can result from using injectable silicone or products being falsely marketed as FDA-approved dermal fillers for the purpose of enhancing the size of their buttocks, breasts and other body parts.

14 Nov 2017

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

14 Nov 2017

FDA approves first drug with digital ingestion tracking system

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken.

14 Nov 2017

Study: Many patients change their behaviors after suffering repeated bouts of C. diff infections

After suffering repeated bouts of debilitating Clostridium difficile infections, many patients significantly change their behaviors, but some precautions may do little to prevent future infections, according to a first-of-its-kind study.

8 Nov 2017

Bulgaria reports outbreaks of bird flu (avian influenza)

Veterinary authorities in Bulgaria have called for culling of nearly 8,000 ducks according to a food safety agency yesterday after two more regions there have reported avian flu infection. According to the agency a total of four outbreaks of bird flu have been registered in Bulgaria at this time.

5 Nov 2017

Headache News and Research

Latest Headache News and Research

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Terror survivors have increased risk of frequent migraine, tension headaches

Opioids after surgery left her addicted. Is that a medical error?

Using atraumatic needles for lumbar punctures decreases risk of complications

Intensive weight management program can help people with type 2 diabetes achieve remission

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

New drugs Erenumab and Fremanezumab show promise for migraine

New immunotherapy study shows positive results in chronic migraine sufferers

Tiny markers in saliva can be used to diagnose duration of a concussion in kids

Small molecules in saliva may offer clues to diagnose and predict duration of concussions

FDA approves new drug to treat bleeding in hemophilia A patients

Can apps slay the medical bill dragon?

FDA warns consumers about injuries, disfigurement from using illegal injectable silicone

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

FDA approves first drug with digital ingestion tracking system

Study: Many patients change their behaviors after suffering repeated bouts of C. diff infections

Bulgaria reports outbreaks of bird flu (avian influenza)

Hot flashes, night sweats in middle-aged women may be linked to high risk of obstructive sleep apnea

FDA grants accelerated approval to new treatment for mantle cell lymphoma

Type of needle used in anesthesia not linked to post-dural puncture headache, study shows

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Headache News and Research

Latest Headache News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in